Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2020 12:52 ET | Source: SEngine Precision Medicine

SEngine Precision Medicine to Present Data Related to the Predictive Value of PARIS® Test, an Organoid-based Drug Response Assay, for Cholangiocarcinoma Patients at 2020 AACR Virtual Meeting Session II

SEATTLE, May 15, 2020 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, a precision oncology company revolutionizing cancer diagnostics and therapies by pre-testing drugs on...
May 13, 2020 17:18 ET | Source: SEngine Precision Medicine

SEngine Precision Medicine to Present Data Related to the Predictive Value of the PARIS® Test for Oncology Drugs Based on Retrospective Analysis at 2020 ASCO Annual Meeting

SEATTLE, May 13, 2020 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, a precision oncology company revolutionizing cancer diagnostics and therapies by pre-testing drugs on...
November 14, 2019 09:08 ET | Source: SEngine Precision Medicine

SEngine Precision Medicine Names Surgical Oncologist and Cancer Care Advocate Dr. Astrid Margossian as Chief Medical Officer

SEATTLE, Washington, Nov. 14, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, an oncology pioneer accelerating cancer drug discovery through its proprietary diagnostic platform known as The...
October 02, 2019 09:00 ET | Source: SEngine Precision Medicine

SEngine Precision Medicine Raises $5.1 Million Series A to Advance Personalized Oncology Drug Discovery Platform

SEATTLE, Wash., Oct. 02, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, an oncology pioneer accelerating cancer drug discovery through its CLIA certified, proprietary diagnostic platform...
August 20, 2019 08:50 ET | Source: SEngine Precision Medicine

SEngine Precision Medicine Announces Experienced Technology Executive Tom Neary as Chief Financial Officer

SEATTLE, Washington, Aug. 20, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, an oncology pioneer accelerating cancer drug discovery through its proprietary diagnostic tool known as the PARIS...
April 25, 2019 09:15 ET | Source: SEngine Precision Medicine

SEngine Precision Medicine Announces Renowned Medicinal Chemist to Join Scientific Advisory Board

SEATTLE, April 25, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, an oncology startup accelerating cancer drug discovery through its proprietary diagnostic tool known as the PARIS Test®, today...
February 05, 2019 08:15 ET | Source: SEngine Precision Medicine

SEngine Precision Medicine Announces Pulitzer Prize Winner and Pioneering Oncologist Dr. Siddhartha Mukherjee to Join Scientific Advisory Board

SEATTLE, Feb. 05, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, a biotech startup redefining how cancer is managed and accelerating life-saving discoveries through the promise of precision...
October 29, 2018 10:15 ET | Source: SEngine Precision Medicine

SEngine Precision Medicine Announces Nobel Prize Winner and Former Fred Hutch Cancer Research Center President Dr. Leland Hartwell to Join Board of Directors

SEATTLE, Oct. 29, 2018 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, a biotech startup delivering on the promise of precision oncology through functional genomics, today welcomed Dr. Leland (Lee)...

keyboard_arrow_left Previous Page